Concepedia

Julian Strange

JS

44

Publications

3.1K

Citations

28

H-Index

1998

Active since

Affiliations

University Hospitals Bristol NHS Foundation Trust(Current)

Golden Jubilee National Hospital

NIHR Bristol Cardiovascular Biomedical Research Unit

Belfast Health and Social Care Trust

University of Bristol

Julian Strange is an author at University Hospitals Bristol NHS Foundation Trust specializing in medicine, cardiovascular disease, and coronary heart disease.

ORCID

Top concepts

Publications per year

1998–2024

44

Publications

44

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study

Martin R. Wilkins, Gideon Paul, Julian Strange et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 379 citations

Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells

John Wharton, Julian Strange, Gigi M. O. Møller et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 366 citations

The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe

Joren Maeremans, Simon Walsh, Paul Knaapen et al. · Journal of the American College of Cardiology · 2016 · 303 citations

, , +2

Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension

Abdelkrim Sebkhi, Julian Strange, Steven C. Phillips et al. · Circulation · 2003 · 255 citations

Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries

Amardeep Ghosh Dastidar, Anna Baritussio, Estefania De Gárate et al. · JACC. Cardiovascular imaging · 2019 · 199 citations · Full text

, , +12

Rows per page

1–5 of 44